Today's edition of The Motley Fool's health-care show Market Checkup covers a new drug application from pharmaceutical giant AstraZeneca and a biotech company rumored to be for sale.
Today's health-care headlines.
Read Next
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo
Advertisement